Northwest Biotherapeutics, Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
NWBO Nasdaq 8731 http://www.nwbio.com 6.06 Stock Up +0.10

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Northwest Biotherapeutics, Inc

Nasdaq stocks posting largest percentage decreases - Mar 7th, 2014 4:02 pm
Risk of Pivotal Study Failure Rises for NewLink and Northwest Bio - Mar 7th, 2014 8:51 am
Panel recommends Northwest Bio brain-cancer trial continue - Mar 7th, 2014 6:55 am
8:04 am Northwest Biotherapeutics Receives Recommendation To Continue With Phase III GBM Brain Cancer Trial Based On Data Safety Monitoring Board's Safety Review - Mar 7th, 2014 6:04 am
Northwest receives recommendation to continue with Phase III brain cancer trial - Mar 7th, 2014 6:02 am
NW Bio Receives Recommendation To Continue With Phase III GBM Brain Cancer Trial Based On Data Safety Monitoring Board's Safety Review - Mar 7th, 2014 6:00 am
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due - Mar 3rd, 2014 8:32 am
Tiny Northwest Biotherapeutics aims to dominate brain cancer - Feb 25th, 2014 11:00 pm
ImmunoCellular: Is Approval Enough? - Feb 24th, 2014 8:48 am
Northwest Is A Good Long-Term Bet - Feb 14th, 2014 8:57 am
NW Bio to Present at BIO CEO and Investor Conference 2014 - Feb 6th, 2014 6:15 am
MARKET PULSE-Apple, Oramed, Caterpillar, Spherix, Biocryst - Jan 27th, 2014 9:38 am
NW Bio Enters Into Agreements For Large-Scale Expansion Of Product Manufacturing, Handling And Distribution - Jan 27th, 2014 6:16 am
NW Bio to Present at Phacilitate's Washington Bioleaders' Immunotherapy 2014 Forum - Jan 27th, 2014 6:15 am
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq - Jan 24th, 2014 3:26 pm
NW Bio To Present At Biotech Showcase 2014 - Jan 9th, 2014 8:07 am
Dendritic Cell Vaccines: A Look Back At Clinical Trials Since 1999 - Jan 2nd, 2014 9:46 am
Northwest Biotherapeutics, Inc (NWBO) Sees Hammer Chart Pattern: Time to Buy? - Jan 2nd, 2014 5:59 am
NW Bio's International Phase III GBM Brain Trial Is Subject Of BBC TV Report In The UK - Dec 30th, 2013 6:15 am
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to - Dec 27th, 2013 2:38 pm